CCL
79
11
WEC
45
2
NKE
33
-7
PX
40
4
RSG
53
2
ES
54
2
BIIB
63
10
INTU
39
4
EXC
58
5
ROST
68
2
BK
75
6
ORCL
26
3
KHC
45
2
SBUX
52
5
TRIP
49
2
SYK
33
-4
INTC
58
2
CLX
55
3
FAST
55
2
OKE
48
3
CCL
79
11
WEC
45
2
NKE
33
-7
PX
40
4
RSG
53
2
ES
54
2
BIIB
63
10
INTU
39
4
EXC
58
5
ROST
68
2
BK
75
6
ORCL
26
3
KHC
45
2
SBUX
52
5
TRIP
49
2
SYK
33
-4
INTC
58
2
CLX
55
3
FAST
55
2
OKE
48
3
Financhill
Back

Mirum Pharmaceuticals, Inc. Stock Predictions

Most Pre-IPO Big Tech Shifts Look Like This at the Start

*DISCLOSURE: This is a paid advertisement for Immersed Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks immersed.com
Buy
62

MIRM
Mirum Pharmaceuticals, Inc.

Last Price:
$100.56
Seasonality Move:
1.91%

7 Day Trial

ALL ACCESS PASS

$ 7

When an AI Platform Gets Pulled by Too Much Demand

DISCLOSURE: This is a paid advertisement for RAD Intel's Reg A offering and involves risk, including the possible loss of principal. Please read the offering circular and related risks at invest.radi

Mirum Pharmaceuticals, Inc. Stock Forecast

  • Over the next 52 weeks, Mirum Pharmaceuticals, Inc. has on average historically risen by 38.4% based on the past 6 years of stock performance.
  • Mirum Pharmaceuticals, Inc. has risen higher in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%
  • Is Mirum Pharmaceuticals, Inc. Stock Undervalued?
    The current Mirum Pharmaceuticals, Inc. [MIRM] share price is $100.47. The Score for MIRM is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • MIRM is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.

Will Mirum Pharmaceuticals, Inc. Stock Go Up Next Year?

  • Over the next 52 weeks, Mirum Pharmaceuticals, Inc. has on average historically risen by 38.4% based on the past 6 years of stock performance.

Mirum Pharmaceuticals, Inc. Stock Rating

Buy
62
Mirum Pharmaceuticals, Inc. (MIRM) is a Buy

Is Mirum Pharmaceuticals, Inc. overpriced?

  • Mirum Pharmaceuticals, Inc. has risen higher in 5 of those 6 years over the subsequent 52-week period, corresponding to a historical accuracy of 83.33%

Mirum Pharmaceuticals, Inc. Stock Price History

Is MIRM stock going to rise?

  • The current trend is moderately bullish and MIRM is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
mirumpharma.com

52-Week Data

52-Week High:
105.74
52-Week Low:
36.88

Prediction Charts

Market Cap:
5.2B
Price in USD:
100.47
Volume:
588.7K
Beta:
1.23

Technical Analysis

SMA50:
82.59
SMA100:
77.29
SMA200:
65.69
52-Wk Change:
96.12%

Stock Predictions

  • Is Mirum Pharmaceuticals, Inc. stock public?
    Yes, Mirum Pharmaceuticals, Inc. is a publicly traded company.
  • What is the Mirum Pharmaceuticals, Inc. stock quote today?
    The Mirum Pharmaceuticals, Inc. stock price is 100.47 USD today.
  • How to buy Mirum Pharmaceuticals, Inc. stock online?
    You can buy Mirum Pharmaceuticals, Inc. shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jan-20 90.27 91.89 92.19 89.47
Jan-21 91.38 93.27 93.99 90.49
Jan-22 92.47 96.03 96.13 91.52
Jan-23 96.23 94.29 96.84 93.19
Jan-26 96.17 96.92 98.49 93.23
Jan-27 96.92 99.27 99.44 95.24
Jan-28 101.50 100.85 101.50 98.46
Jan-29 100.70 102.92 103.81 100.01
Jan-30 102.85 103.22 103.72 100.62
Feb-2 103.11 103.80 105.11 101.79
Feb-3 104.15 105.45 105.64 102.75
Feb-4 105.74 103.96 105.74 100.86
Feb-5 104.12 98.23 104.12 97.58
Feb-6 100.02 100.47 101.08 97.49

Mirum Pharmaceuticals, Inc. Earnings

Mirum Pharmaceuticals, Inc. Earnings Report: Per Share Mirum Pharmaceuticals, Inc. Earnings Q1 Q2 Q3 and Q4 last year and next year.

Mirum Pharmaceuticals, Inc. Forecast Revenue Growth

Mirum Pharmaceuticals, Inc. Stock Analysis: Historical quarterly revenues per share for Mirum Pharmaceuticals, Inc. and historical quarterly revenue growth:

  • Analysts estimate an earnings increase this quarter of $0.21 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.29 per share, and an increase next year of $0.18 per share.

* Mirum Pharmaceuticals, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.